google-site-verification: googlec7193c3de77668c9.html

Study shows benefits in obesity-linked conditions of losing more weight with GLP-1 treatment

[
New research presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12–15 May) shows that, following treatment for obesity or diabetes or both, using incretin-based drugs, losing more weight versus less weight, and losing a little weight versus gaining weight, both lead to a relatively lower risk of obesity-related conditions. The study is by Professor John Wilding of the University of Liverpool, UK, and colleagues.


Source link

Advertisements
Views: 0

See also  Workplace drinking in focus: How one free case of nonalcoholic drinks can cut short-term alcohol intake

Check Also

Billions of doses later: Global review confirms mRNA vaccines are safe, effective and full of promise

[ A sweeping global review led by researchers at the University of British Columbia has …

Treatment for alcohol use disorder can reverse harmful brain effects

[ When we drink alcohol, our liver breaks it down into acetate, which the body …

New framework highlights overlooked ecological factors in nature prescribing

[ A one health sustainability framework for nature-based wellbeing. Credit: Environmental Research Letters (2026). DOI: …

Leave a Reply

Available for Amazon Prime